On July 13, 2026, Linear Health Sciences announced that Japanese medical device manufacturer NIPRO will begin distributing its Orchid Safety Release Valve (SRV) in the Japanese market beginning July 22, 2026. The device is designed to prevent unintentional IV catheter dislodgement by introducing a mechanism that safely disconnects when excessive force is applied. Wilson Sonsini Goodrich & Rosati advised NIPRO on the transaction.

Linear and NIPRO established an exclusive distribution agreement in March 2026 that grants NIPRO the sole rights to market and distribute the Orchid SRV in Japan.

The Wilson Sonsini team that advised NIPRO on the transaction includes Seth Flaum and Christina Fuleihan.

For more information, please see Linear Health Sciences’ news release.